医学
CD30
淋巴瘤
霍奇金淋巴瘤
肿瘤科
价值(数学)
内科学
癌症研究
机器学习
计算机科学
标识
DOI:10.1016/s2352-3026(24)00094-2
摘要
The use of chimeric antigen receptor (CAR) T cells in haematological malignancies is becoming increasingly widespread, with several authorised drugs and many patients benefiting from their efficacy and manageable tolerance in the short and medium term.
科研通智能强力驱动
Strongly Powered by AbleSci AI